Jafron Biomedical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
126,784.60
160,048.20
200,441.00
202,118.50
284,451.90
400,945.50
Depreciation, Depletion & Amortization
3,095.00
4,414.00
9,776.10
16,815.40
16,405.00
22,176
Other Funds
-
-
-
420,561.60
139,634.90
13,152.30
Funds from Operations
130,341.30
165,864.60
210,807.50
221,189.90
305,440.50
433,340.30
Changes in Working Capital
2,984.50
28,510.40
5,629.40
40,515.90
29,079.70
10,585.80
Net Operating Cash Flow
133,325.80
137,354.20
205,178.10
180,674.00
334,520.20
422,754.50
Capital Expenditures
63,143.40
64,289.90
61,402.60
28,655.00
177,728.60
Sale of Fixed Assets & Businesses
4.00
63.90
1.40
175.90
70.30
Purchase/Sale of Investments
-
-
-
100,000.00
100,000.00
Net Investing Cash Flow
60,989.30
65,123.00
61,901.20
128,479.10
89,759.50
Cash Dividends Paid - Total
37,500.00
87,750.00
88,800.00
-
83,320.80
Net Financing Cash Flow
37,500.00
87,750.00
88,800.00
420,561.60
56,314.10
Net Change in Cash
34,836.50
15,518.80
54,476.90
472,756.50
301,074.90
Free Cash Flow
70,299.90
74,134.10
145,095.10
152,019.00
156,791.50
Deferred Taxes & Investment Tax Credit
45.60
277.80
339.30
276.10
702.60
2,933.50
Net Assets from Acquisitions
1,673.50
897.10
500.00
-
12,101.20
Other Sources
3,823.80
-
-
-
-
Exchange Rate Effect
0.00
-
0.00
0.00
0.20
About Jafron Biomedical Co.
View Profile
